BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braat AJ, Huijbregts JE, Molenaar IQ, Borel Rinkes IH, van den Bosch MA, Lam MG. Hepatic radioembolization as a bridge to liver surgery. Front Oncol. 2014;4:199. [PMID: 25126539 DOI: 10.3389/fonc.2014.00199] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Appalanaido GK, Ahmad MZ, Shukor SA, Cheen Hoe AK, Subramaniam MK, Fan AS, Abdul Aziz MZ. Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient. Hepat Oncol 2022;9:HEP44. [PMID: 36176484 DOI: 10.2217/hep-2021-0014] [Reference Citation Analysis]
2 Papamichail M, Pizanias M, Heaton ND, M P, M P, Nd H. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00230-7. [PMID: 34961675 DOI: 10.1016/j.hbpd.2021.12.005] [Reference Citation Analysis]
3 Shah RM, Sheikh S, Shah J, Vivian E, Mejia A, Shahin I, Mantry PS. Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center. J Gastrointest Oncol 2021;12:1718-31. [PMID: 34532122 DOI: 10.21037/jgo-20-435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alem Z, Murray TE, Egri C, Chung J, Liu D, Elsayes KM, Chang SD, Harris A. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3596-614. [PMID: 33909092 DOI: 10.1007/s00261-021-03095-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dikilitas M. Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better? J Gastrointest Cancer 2020;51:1193-6. [PMID: 32869146 DOI: 10.1007/s12029-020-00497-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gordon AC, White SB, Yang Y, Gates VL, Procissi D, Harris KR, Zhang Z, Lyu T, Huang X, Dreher MR, Omary RA, Salem R, Lewandowski RJ, Larson AC. Feasibility of Combination Intra-arterial Yttrium-90 and Irinotecan Microspheres in the VX2 Rabbit Model. Cardiovasc Intervent Radiol 2020;43:1528-37. [PMID: 32533312 DOI: 10.1007/s00270-020-02538-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jeyarajah DR, Doyle MBM, Espat NJ, Hansen PD, Iannitti DA, Kim J, Thambi-Pillai T, Visser BC. Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm. J Gastrointest Oncol 2020;11:443-60. [PMID: 32399284 DOI: 10.21037/jgo.2020.01.09] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
8 Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, Pawlik TM, Tsung A, Cloyd JM. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World J Gastroenterol 2019; 25(28): 3704-3721 [PMID: 31391767 DOI: 10.3748/wjg.v25.i28.3704] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 68] [Article Influence: 21.7] [Reference Citation Analysis]
9 Guidoccio F, Boni G, Volterrani D, Mariani G. Radionuclide Therapy for Tumors of the Liver and Biliary Tract. Nuclear Medicine Textbook 2019. [DOI: 10.1007/978-3-319-95564-3_33] [Reference Citation Analysis]
10 Voutsinas N, Lekperic S, Barazani S, Titano JJ, Heiba SI, Kim E. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques. J Nucl Med 2018;59:1649-54. [PMID: 30072501 DOI: 10.2967/jnumed.116.186346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Joo I, Kim HC, Kim GM, Paeng JC. Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know. Korean J Radiol 2018;19:209-22. [PMID: 29520178 DOI: 10.3348/kjr.2018.19.2.209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
12 Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V, Maleux G, Pinna AD, Bester L, Morris DL, Iannitti D, Chow PK, Stubbs R, Gow PJ, Masi G, Fisher KT, Lau WY, Kouladouros K, Katsanos G, Ercolani G, Rotellar F, Bilbao JI, Schoen M. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres. Ann Surg Oncol. 2017;24:2465-2473. [PMID: 28653161 DOI: 10.1245/s10434-017-5950-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
13 Boni G, Guidoccio F, Volterrani D, Mariani G. Radionuclide Therapy of Tumors of the Liver and Biliary Tract. Nuclear Oncology 2017. [DOI: 10.1007/978-3-319-26236-9_51] [Reference Citation Analysis]
14 Lanza E, Donadon M, Poretti D, Pedicini V, Tramarin M, Roncalli M, Rhee H, Park YN, Torzilli G. Transarterial Therapies for Hepatocellular Carcinoma. Liver Cancer 2016;6:27-33. [PMID: 27995085 DOI: 10.1159/000449347] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
15 Starlinger P, Assinger A, Brostjan C, Gruenberger T. Liver surgery for metastatic colorectal cancer: the surgical oncologist perspective. Colorectal Cancer 2016;5:115-25. [DOI: 10.2217/crc-2016-0004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Cucchetti A, Cappelli A, Ercolani G, Mosconi C, Cescon M, Golfieri R, Pinna AD. Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies. Liver Cancer. 2016;5:303-311. [PMID: 27781202 DOI: 10.1159/000449341] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lau WY, Teoh YL, Win KM, Lee RC, de Villa VH, Kim YH, Liang PC, Santos-Ocampo RS, Lo RH, Lim KB, Tai DW, Ng DC, Irani FG, Gogna A, Chow PK. Current role of selective internal radiation with yttrium-90 in liver tumors. Future Oncol 2016;12:1193-204. [PMID: 27007495 DOI: 10.2217/fon-2016-0035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
18 Boni G, Guidoccio F, Volterrani D, Mariani G. Radionuclide Therapy of Tumors of the Liver and Biliary Tract. Nuclear Oncology 2016. [DOI: 10.1007/978-3-319-26067-9_51-1] [Reference Citation Analysis]
19 Habito CM. Editorial: Radioembolization in the Treatment of Liver Cancer: A Multidisciplinary Approach for Individualized Therapy. Front Oncol 2015;5:216. [PMID: 26500889 DOI: 10.3389/fonc.2015.00216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Braat AJ, Smits ML, Braat MN, van den Hoven AF, Prince JF, de Jong HW, van den Bosch MA, Lam MG. ⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments. J Nucl Med 2015;56:1079-87. [PMID: 25952741 DOI: 10.2967/jnumed.115.157446] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]